KEAP1 and cancer: Recent studies have emphasized the significance of targeting the nuclear factor erythroid 2-related factor 2 (NRF2)–KEAP1 axis in various diseases, including cancer, due to the cytoprotective functions of proteins encoded by NRF2-target genes, such as those involved in antioxidant defense, detoxification, and anti-inflammatory processes [116].